EFFECT OF AZACYTIDINE IN THE RELEASE OF LEUKEMIA INHIBITORY FACTOR, ONCOSTATIN M, INTERLEUKIN (IL)-6, AND IL-11 BY MONONUCLEAR CELLS OF PATIENTS WITH REFRACTORY ANEMIA-Reference-Cited by-同舟云学术

EFFECT OF AZACYTIDINE IN THE RELEASE OF LEUKEMIA INHIBITORY FACTOR, ONCOSTATIN M, INTERLEUKIN (IL)-6, AND IL-11 BY MONONUCLEAR CELLS OF PATIENTS WITH REFRACTORY ANEMIA

Published:2002-11 Issue:4 Volume:20 Page:154-162
ISSN:1043-4666
Container-title:Cytokine
language:en
Short-container-title:Cytokine

Author:

López-Karpovitch Xavier,Barrales-Benı́tez Olga,Flores Martı́n,Piedras Josefa

Publisher

Elsevier BV

Subject

Molecular Biology,Hematology,Biochemistry,Immunology,Immunology and Allergy

Reference50 articles.

1. World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues: Report of the Clinical Advisory Committee Meeting-Airlie House, Virginia, November 1997;Harris;J Clin Oncol,1999

2. A paradigm shift in myelodysplastic syndromes;Raza;Leukemia,1996

3. Measurement of serum cytokine levels in patients with myelodysplastic syndromes;Verhoef;Leukemia,1992

4. Overexpression of tumor necrosis factor (TNF)-α and interferon (INF)-γ by bone marrow cells from patients with myelodysplastic syndromes;Kitagawa;Leukemia,1997

5. In vitro studies of erythropoietin-depedent regulation of erythropoiesis in myelodysplastic syndromes;Merchav;Leukemia,1990

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Antileishmanial potentials of azacitidine and along with meglumine antimoniate on Leishmania major: In silico prediction and in vitro analysis;PLOS ONE;2023-09-08

2. Identification of hub genes and key pathways in pediatric Crohn’s disease using next generation sequencing and bioinformatics analysis;2022-07-28

3. Laboratory and clinical risk assessment to treat myelodysplatic syndromes;Clinical Chemistry and Laboratory Medicine (CCLM);2016-09-01

4. Azacitidine;Drugs;2012-05

5. The role of p38 mitogen-activated protein kinase in serum-induced leukemia inhibitory factor secretion by bone marrow stromal cells from pediatric myelodysplastic syndromes;Leukemia Research;2010-04